Viewing nowCombinationDukael Tablets 60/2.5 mg
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.

MFDS item code 202300114 · Approved 2023.01.06 · Insurance code 647304500
Improves blood pressure control in essential hypertension
This medication is used for essential hypertension in patients whose blood pressure is not adequately controlled with Pimasartan monotherapy. It effectively lowers blood pressure and helps reduce the risk of complications associated with hypertension. Therefore, it plays a role in improving treatment when blood pressure management is challenging.
The recommended dosage for this medication is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning) whenever possible.
This medication may cause serious harm or death to the fetus and newborn during the second and third trimesters of pregnancy. If pregnancy is confirmed, cease use immediately. This medication should not be used in some patients, including those with allergies to its components, those who are pregnant or breastfeeding, patients undergoing kidney dialysis, severe liver impairment, or bile duct obstruction. Patients with low blood volume or sodium, impaired kidney function, certain heart valve diseases, and the elderly should use this medication cautiously and be monitored closely. Common side effects during use include dizziness, headache, facial or peripheral edema, urinary disorders, insomnia, flushing, etc. Consult a doctor if any unusual symptoms occur. Patients with low blood pressure or electrolyte imbalances should take particular care, and if blood pressure drops too low, appropriate treatment must be sought immediately. This medication may increase potassium levels, so patients with heart failure or kidney impairment should have their serum potassium levels regularly monitored. When taking this medication with other antihypertensives, certain diuretics, lithium, or non-steroidal anti-inflammatory drugs, drug interactions may occur; therefore, consultation with a doctor or pharmacist is essential. Pregnant or breastfeeding women are advised not to take this medication and should make decisions in consultation with a specialist if necessary. Use in children under 18 is not recommended as safety and efficacy have not been established. In case of overdose, severe hypotension, tachycardia, or shock may occur, and it is imperative to visit a medical facility immediately for emergency treatment. Store this medication out of reach of children and avoid transferring it to different containers.
Urticaria, severe swelling (edema), difficulty breathing, yellowing of the skin or eyes (jaundice), sudden and severe headache, seizures, confusion of consciousness, paralysis, markedly reduced urine output, severe generalized swelling associated with elevated blood pressure, toxic epidermal necrolysis, severe allergic reactions, severe edema, or urinary abnormalities, serious neurological symptoms, liver abnormalities (jaundice), respiratory problems.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in containers that block light, at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness and prevent degradation.
Yellow, rounded square film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.